Kim Kelderman

President, Bio-Techne.

Companies

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

As of each latest filing. The line shows shares held over time.

Recent filings

  • Sep 8, 2026Exercised options 500 shares of CONMED Corporation7
  • Aug 15, 2026Shares withheld for tax 10,821 shares at $72.40 of Bio-Techne8
  • Aug 15, 2026Exercised options 21,470 shares of Bio-Techne8
  • Jul 28, 2026Shares withheld for tax 28,686 shares at $72.07 of Bio-Techne9
  • Jul 28, 2026Exercised options 35,000 shares at $47.60 of Bio-Techne9
  • May 5, 2026Shares withheld for tax 23,951 shares at $56.68 of Bio-Techne10
  • May 5, 2026Exercised options 26,692 shares at $47.60 of Bio-Techne10
  • Apr 22, 2026Shares withheld for tax 1,363 shares at $58.58 of Bio-Techne11
  • Apr 22, 2026Exercised options 11,344 shares of Bio-Techne11
  • Apr 14, 2026Shares withheld for tax 32,088 shares at $58.66 of Bio-Techne12
  • Apr 14, 2026Exercised options 36,500 shares of Bio-Techne12
  • Nov 3, 2025Shares withheld for tax 2,303 shares at $62.57 of Bio-Techne13
  • Aug 15, 2025Shares withheld for tax 4,305 shares at $53.60 of Bio-Techne14
  • Aug 15, 2025Exercised options 8,543 shares of Bio-Techne14
  • Jul 22, 2025Shares withheld for tax 43,649 shares at $53.12 of Bio-Techne15
  • Jul 22, 2025Exercised options 48,176 shares at $44.33 of Bio-Techne15
  • Jul 15, 2025Shares withheld for tax 32,933 shares at $51.42 of Bio-Techne16
  • Jul 15, 2025Exercised options 36,132 shares at $44.33 of Bio-Techne16
  • Jan 27, 2025Sold 1,661 shares at $77.95 of Bio-Techne17
  • Jan 27, 2025Sold 11,731 shares at $77.19 of Bio-Techne17
  • Jan 27, 2025Exercised options 13,392 shares at $37.70 of Bio-Techne17
  • Nov 1, 2024Shares withheld for tax 2,430 shares at $75.31 of Bio-Techne18
  • Aug 29, 2024Exercised options 1,492 shares at $66.97 of Bio-Techne19
  • Jul 31, 2024Shares withheld for tax 9,479 shares at $81.97 of Bio-Techne20
  • Jul 31, 2024Exercised options 14,000 shares at $37.70 of Bio-Techne20